Company: LNAI
Filing Date: 2025-02-19
Form Type: 10-K/A
Source: 0001731122-25-000252
Chunk: 3

Company: Lunai Bioworks Inc.
Filing Date: 2025-02-19
Form: 10-K/A
Chunk 3
---
 of the June 30, 2024, financial statements should no longer be relied upon. The Company is restating the June 30, 2024,
financial statements within this Amendment.

During the preparation of the Company’s
Form 10-Q for the period ended December 31, 2024, the Company determined that certain warrants which were exercised during the three months
ended March 31, 2024, had not been appropriately reflected as a component of the change in fair value of the contingent consideration
for the year ended June 30, 2024.

Refer to “Note 2 - Restatement of Previously Issued Financial Statements” of “Part II - Item 8. Financial Statements” (“Note 2”) for
additional information.

Internal Control Considerations

Due to discovery of the error, the Company’s management re-evaluated
the effectiveness of the Company’s internal control over financial reporting (“ICFR”) as of June 30, 2024 and believes
the error relates to and is the result of a previously identified and reported material weakness which has been disclosed in our 2024
Form 10-K. The material weakness remained in place as of June 30, 2024. For a discussion of management’s consideration of disclosure
controls and procedures, internal controls over financial reporting and the material weaknesses identified, see “Part II - Item
9A. Controls and Procedures” of this Amendment.

Items Amended in this Amendment

This Amendment amends and restates
the following items included in the original filing as appropriate to reflect the restatement of the relevant periods:

| ● | Part                                                      
 II - Item 8. Financial Statements and Supplementary Data; |

| ● | Part                                                                                                    
 II - Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations; and |

| ● | Part                   
 IV, Item 15. Exhibits. |

This Amendment includes new certifications
by our principal executive officer and principal financial officer pursuant to Sections 302 and 906 of the Sarbanes-Oxley Act of
2002 dated as of this filing in connection with this Form 10-K/A as Exhibits 31.1, 31.2, 32.1 and 32.2 hereto.

Except as described in Note 2,
no other information included in the 2024 Form 10-K is being amended or updated by this Amendment and, other than as described herein,
this Amendment does not purport to reflect any information or